Roth Capital Downgrades INVO Bioscience Inc. (invo) to Neutral

April 13, 2022 3:27 AM EDT
Get Alerts invo Hot Sheet
Price: $0.83 --0%

Rating Summary:
    2 Buy, 2 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE

Roth Capital analyst Scott Henry downgraded INVO Bioscience Inc. (NASDAQ: invo) from Buy to Neutral with a price target of $2.00 (from $4.00).


For an analyst ratings summary and ratings history on INVO Bioscience Inc. click here. For more ratings news on INVO Bioscience Inc. click here.


Shares of INVO Bioscience Inc. closed at $2.14 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades